Literature DB >> 12151302

A matrix for new ideas in pulmonary fibrosis.

Donald N Cook1, David M Brass, David A Schwartz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12151302     DOI： 10.1165/ajrcmb.27.2.f245

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN： 1044-1549            Impact factor:   6.914


× No keyword cloud information.
  10 in total

Review 1.  Signaling pathways in the epithelial origins of pulmonary fibrosis.

Authors:  William D Hardie; James S Hagood; Vrushank Dave; Anne-Karina T Perl; Jeffrey A Whitsett; Thomas R Korfhagen; Stephan Glasser
Journal:  Cell Cycle       Date:  2010-07-03       Impact factor: 4.534

2.  The efficiency of a urotensin II antagonist in an experimental lung fibrosis model.

Authors:  Ahmet Mesut Onat; Ibrahim Halil Turkbeyler; Yavuz Pehlivan; Tuncer Demir; Davut Sinan Kaplan; Seyithan Taysi; Ali Osman Ceribasi; Ediz Tutar; Bunyamin Kisacik
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

3.  SP-1 regulation of MMP-9 expression requires Ser586 in the PEST domain.

Authors:  Shubha Murthy; Alan J Ryan; A Brent Carter
Journal:  Biochem J       Date:  2012-07-15       Impact factor: 3.857

4.  Substrate stiffness regulates extracellular matrix deposition by alveolar epithelial cells.

Authors:  Jessica L Eisenberg; Asmahan Safi; Xiaoding Wei; Horacio D Espinosa; Gr Scott Budinger; Desire Takawira; Susan B Hopkinson; Jonathan Cr Jones
Journal:  Res Rep Biol       Date:  2011-01

5.  Imaging in detecting sites of pulmonary fibrosis induced by paraquat.

Authors:  Xiao-Li Xu; Wei Wang; Zu-Jun Song; Hong Ding; Xiao-Hong Duan; Huan-Cheng Meng; Jian Chong
Journal:  World J Emerg Med       Date:  2011

6.  Inhibition of PI3K by PX-866 prevents transforming growth factor-alpha-induced pulmonary fibrosis.

Authors:  Timothy D Le Cras; Thomas R Korfhagen; Cynthia Davidson; Stephanie Schmidt; Matthew Fenchel; Machiko Ikegami; Jeffrey A Whitsett; William D Hardie
Journal:  Am J Pathol       Date:  2009-12-30       Impact factor: 4.307

7.  Rapamycin prevents transforming growth factor-alpha-induced pulmonary fibrosis.

Authors:  Thomas R Korfhagen; Timothy D Le Cras; Cynthia R Davidson; Stephanie M Schmidt; Machiko Ikegami; Jeffrey A Whitsett; William D Hardie
Journal:  Am J Respir Cell Mol Biol       Date:  2009-02-24       Impact factor: 6.914

8.  Attenuation of bleomycin induced pulmonary fibrosis in mice using the heme oxygenase inhibitor Zn-deuteroporphyrin IX-2,4-bisethylene glycol.

Authors:  L Atzori; F Chua; S E Dunsmore; D Willis; M Barbarisi; R J McAnulty; G J Laurent
Journal:  Thorax       Date:  2004-03       Impact factor: 9.139

9.  Rapamycin Regulates Bleomycin-Induced Lung Damage in SP-C-Deficient Mice.

Authors:  Satish K Madala; Melissa D Maxfield; Cynthia R Davidson; Stephanie M Schmidt; Daniel Garry; Machiko Ikegami; William D Hardie; Stephan W Glasser
Journal:  Pulm Med       Date:  2011-03-21

10.  Blockade of advanced glycation end product formation attenuates bleomycin-induced pulmonary fibrosis in rats.

Authors:  Lei Chen; Tao Wang; Xun Wang; Bei-Bei Sun; Ji-Qiong Li; Dai-Shun Liu; Shang-Fu Zhang; Lin Liu; Dan Xu; Ya-Juan Chen; Fu-Qiang Wen
Journal:  Respir Res       Date:  2009-06-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.